BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7848583)

  • 1. Plasma type IV collagen and fibronectin concentrations in diabetic patients with microangiopathy.
    Lee IK; Park KY; Oh HK; Park RW; Jo JS
    J Korean Med Sci; 1994 Aug; 9(4):341-6. PubMed ID: 7848583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum type IV collagen concentrations in diabetic patients with microangiopathy as determined by enzyme immunoassay with monoclonal antibodies.
    Matsumoto E; Matsumoto G; Ooshima A; Kikuoka H; Bessho H; Miyamura K; Nanjo K
    Diabetes; 1990 Aug; 39(8):885-90. PubMed ID: 1695588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum and urinary concentrations of type IV collagen and laminin as a marker of microangiopathy in diabetes.
    Hayashi Y; Makino H; Ota Z
    Diabet Med; 1992 May; 9(4):366-70. PubMed ID: 1600709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum and urinary type IV collagen concentrations in the assessment of diabetic microangiopathy.
    Banu N; Hara H; Egusa G; Yamakido M
    Hiroshima J Med Sci; 1994 Dec; 43(4):123-33. PubMed ID: 7883578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma fibronectin, von Willebrand factor antigen, and blood rheology. Association with diabetic microvascular disease.
    Solerte SB; Piovella F; Viola C; Schianca GC; Gamba G; Fioravanti M; Ferrari E
    Acta Diabetol Lat; 1985; 22(3):239-46. PubMed ID: 3878055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel advanced glycation index and its association with diabetes and microangiopathy.
    Sampathkumar R; Balasubramanyam M; Rema M; Premanand C; Mohan V
    Metabolism; 2005 Aug; 54(8):1002-7. PubMed ID: 16092048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum concentrations of intact type IV collagen in diabetics.
    Matsumoto E; Matsumoto G; Bessho H; Kikuoka H; Nanjo K
    J Diabet Complications; 1991; 5(2-3):189-90. PubMed ID: 1770042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma homocysteine and microvascular complications in type 1 diabetes.
    Vaccaro O; Perna AF; Mancini FP; Iovine C; Cuomo V; Sacco M; Tufano A; Rivellese AA; Ingrosso D; Riccardi G
    Nutr Metab Cardiovasc Dis; 2000 Dec; 10(6):297-304. PubMed ID: 11302003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum or urinary concentration of type IV collagen in diabetics.
    Watanabe T; Negishi K; Katayama S; Ishii J; Kawazu S
    J Diabet Complications; 1991; 5(2-3):191-2. PubMed ID: 1770043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Plasma fibronectin and collagen type IV in diabetic patients. Influence of therapy].
    Alland A; Hartmann DJ; Loupy G; Lechevalier D; Ville G; Cotisson A; Ulrich JY
    Pathol Biol (Paris); 1984 Feb; 32(2):115-21. PubMed ID: 6701012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormal metabolism of type-IV collagen in normotensive non-insulin-dependent diabetes mellitus patients.
    Sumida Y; Ura H; Yano Y; Misaki M; Shima T
    Horm Res; 1997; 48(1):23-8. PubMed ID: 9195206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skin collagen pentosidine and fluorescence in diabetes were predictors of retinopathy progression and creatininemia increase already 6years after punch-biopsy.
    Sternberg M; M'bemba J; Urios P; Borsos AM; Selam JL; Peyroux J; Slama G
    Clin Biochem; 2016 Feb; 49(3):225-31. PubMed ID: 26506116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma thrombomodulin: a marker for microvascular complications in diabetes mellitus.
    Gabat S; Keller C; Kempe HP; Amiral J; Ziegler R; Ritz E; Bergis KH; Wahl P; Nawroth P
    Vasa; 1996; 25(3):233-41. PubMed ID: 8795304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of irisin concentrations with the presence of diabetic nephropathy and retinopathy.
    Hu W; Wang R; Li J; Zhang J; Wang W
    Ann Clin Biochem; 2016 Jan; 53(Pt 1):67-74. PubMed ID: 25814621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood levels of total homocysteine in patients with type 1 diabetes (with no complications, diabetic nephropathy and/or retinopathy) and in their non-diabetic relatives.
    Matteucci E; Rossi L; Mariani S; Fagnani F; Quilici S; Cinapri V; Giampietro O
    Nutr Metab Cardiovasc Dis; 2002 Aug; 12(4):184-9. PubMed ID: 12514938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Von Willebrand factor (VIII R:Ag), fibronectin, and insulin-like growth factors I and II in diabetic retinopathy and nephropathy.
    Lamberton RP; Goodman AD; Kassoff A; Rubin CL; Treble DH; Saba TM; Merimee TJ; Dodds WJ
    Diabetes; 1984 Feb; 33(2):125-9. PubMed ID: 6363166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum Levels of Progranulin Are Closely Associated with Microvascular Complication in Type 2 Diabetes.
    Xu L; Zhou B; Li H; Liu J; Du J; Zang W; Wu S; Sun H
    Dis Markers; 2015; 2015():357279. PubMed ID: 26106251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinico-diagnostic significance of fibronectin determination in diabetes mellitus in children].
    Popova VA; Ostashevskaia MI; Podgorodnichenko VK
    Pediatriia; 1990; (6):9-12. PubMed ID: 2395632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma fibronectin in diabetic retinopathy and macroangiopathy.
    Seghieri G; Bartolomei G; De Giorgio LA
    Diabete Metab; 1986 Aug; 12(4):186-90. PubMed ID: 3770274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum cystatin C in diabetic patients. Not only an indicator for renal dysfunction in patients with overt nephropathy but also a predictor for cardiovascular events in patients without nephropathy.
    Ogawa Y; Goto T; Tamasawa N; Matsui J; Tando Y; Sugimoto K; Tomotsune K; Kimura M; Yasujima M; Suda T
    Diabetes Res Clin Pract; 2008 Feb; 79(2):357-61. PubMed ID: 17980929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.